← Back to J.B. Chemicals & Pharmaceuticals Ltd. overview
J.B. Chemicals & Pharmaceuticals Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹3,862 cr | ₹660 cr | ₹41.56 | ₹4,274 cr | ₹3,433 cr | 19.21% | 25.95% | 0.01x | 17.08% |
| FY2024 | ₹3,448 cr | ₹553 cr | ₹34.85 | ₹3,994 cr | ₹2,923 cr | 18.9% | 24.09% | 0.13x | 16.03% |
| FY2023 | ₹3,117 cr | ₹410 cr | ₹26.17 | ₹3,554 cr | ₹2,480 cr | 16.52% | 19.35% | 0.23x | 13.15% |
| FY2022 | ₹2,424 cr | ₹385 cr | ₹24.91 | ₹2,607 cr | ₹2,134 cr | 18.06% | 23.3% | 0.03x | 15.9% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.